Non-Invasive Quantum Systems
Wearable Insights, Smarter Living
About us
NIQS is redefining personal health through cutting-edge, needle-free glucose tracking; effortless, intelligent insights designed for those who demand the best in modern wellness technology.
Driven by innovation, our vision is to lead non-invasive sensing, adapting our core IP to transform not only personal health, but the wider landscape of connected, data-driven wellbeing.
Guided by a commitment to enhancing quality of life, we fuse precision engineering with responsible innovation, creating technology that empowers people while respecting our planet.
Team
-
Nicholas Furtak-Wells, PhD
Chief Executive Officer
Nicholas holds a PhD in quantum optics from Leeds University and is responsible for leading NIQS commercial strategy and driving the business forward.
He is one of the co-founders and co-inventors of NIQS’ technology. He is also the recipient of the prestigious QTEC and Royal Society of Edinburgh enterprise fellowships, as well as receiving support from the Innovate UK ICURe programme.
-
Benjamin Dawson, PhD
Chief Technical Officer
Benjamin holds a PhD in quantum optics from Leeds University and is responsible for leading R&D develop our revolutionary technology into a market-ready product.
He is one of the co-founders and co-inventors of NIQS’ technology, and has several years’ experience with running his own business. His cutting-edge research was supported by the NQIT (Networked Quantum Information Technologies) hub.
-
Robert Mathieson, PhD
Chief Operations Officer
Robert holds a PhD in photonic materials from Leeds University, and is a world-expert in the photonic chip technology that NIQS is exploiting for our sensing applications.
He is one of the co-founders and co-inventors of NIQS’ technology, and brings a wealth of commercial, technical, and operational experience that he garnered from building two spin-out companies, where he managed staff and lab operations.
-
Ioanna Pallikara, PhD
Lead Data Scientist
Ioanna holds a PhD in theoretical chemistry from the University of Manchester, where she applied machine learning for materials modelling and further refined these skills during her postdoctoral research. In her current role at NIQS Tech, she develops our advanced machine learning algorithms.She is passionate about applying AI and data science techniques to tackle complex challenges across science and technology.
Advisory board
-
![]()
Erno Klaassen
Strategic Advisor - Erno brings over 12 years of leadership as Senior Director of Health Technologies at Apple.
With deep expertise across biomedical / electrical engineering, physiological sensing, and system integration, he has a proven track record of taking products from research through to global launch.
Erno understands the digital health space inside out; deeply understanding development cycles, stakeholders’ requirements, and who the key players are. His industry reputation and extensive network enable him to open doors, accelerate development, and build favourable partnerships that create a long-term strategic advantage for NIQS.
-
![]()
Prof Gin Jose
Scientific Advisor - Photonic devices and materials
Gin is a globally recognised expert in photonics and has over 20 years experience developing photonic devices and materials, he is one of the co-founders of NIQS and co-inventors of the technology we are commercialising.
He is the Chair of Functional Materials at Leeds University and has previously formed several spin-out companies to commercialise his research.
-
![]()
Prof Ramzi Ajjan
Clinical Advisor - NHS Consultant in diabetes & endocrinology
Ramzi is a consultant in diabetes and endocrinology at the Leeds Teaching Hospitals NHS Trust, and he is also a professor of metabolic medicine.
His clinical practice is concentrated on managing young adults with type 1 diabetes, and complex patients with type 2 diabetes. He is the local R&D lead for diabetes and endocrinology in Leeds and regional Clinical Research Network co-lead in diabetes, endocrine and metabolic disorders. He is deputy Chair of Clinical Study Group 2 at Diabetes UK and Associate Editor of Diabetes and Vascular Disease Research.
-
![]()
Ian McEwan
Commercial Advisor - Dr Ian McEwan supports our business strategy and supports the management team at the board level as a non-executive director.
He has over 20 years’ experience as COO/CFO/Commercial Director across a diverse portfolio of companies including PervasID, RAND corporation, ZinWave, ProQuest, Cresspoint and Unilever.
He has successfully raised VC funding for 10 different businesses and has extensive experience in developing and implementing business growth strategies.
-
![]()
Prof Almut Beige
Scientific Advisor - Quantum optics and Quantum technologies
Almut is world-renowned expert in quantum optics and quantum technologies, and she is also one of the co-founders and co-inventors of NIQS’ revolutionary sensing technology.
She is the Head of Theoretical Physics at Leeds University, and has previous experience working with and helping academics to form spin-out companies to commercialise their academic research.
-
![]()
Prof Sikha Saha
Clinical advisor - In-vitro trials and biosensor expert
Sikha is a professor of cerebrovascular medicine who has more than 20 years experience conducting both in-vitro and clinical trials.
She also has extensive experience developing and validating point-of-care biosensors and other types of bioimaging tools.
Technology
NIQS’ takes on sensing using a fundamentally different approach to existing methods and techniques.
Rather than using traditional approaches which have numerous limiting factors, NIQS is utilising a novel optical interaction to extract information.
These interactions form our sensing mechanism that enable us to perform targeted measurements within the system or sample we wish to investigate non-invasively.
News
NIQS DELIVERS NON-INVASIVE GLUCOSE MONITORING WITH 99.3% ACCURACY
